Bayer shareholder calls for new board membersOne of Bayer's top shareholders, Deka Investment, openly called for quickly hiring new supervisory board members, reported Frankfurter Allgemeine Zeitung (FAZ) on Wednesday (p22).
German health minister receives backing for compulsory measles vaccinationGerman health minister Jens Spahn received backing from several health lobbies after he presented his plans to introduce compulsory measles vaccination for children attending daycare centres or schools on Sunday, reported FAZ (p1), Süddeutsche Zeitung (SZ) (p1, 4) and Die Welt (p11) on Monday.
Merck KGaA buys U.S. special materials manufacturer IntermolecularGermany's Merck KGaA has acquired the Californian company Intermolecular for approximately $62 million, FAZ reported on Tuesday (p20).
Merck KGaA expands cooperation with European Space AgencyMerck KGaA has expanded its current cooperation with the European Space Agency (ESA) on biosensors, digitalisation and materials research, reported FAZ on Wednesday (p40).
Novartis 'broke open piggy bank' for Takeda's eye drugNovartis broke open the piggy bank to buy Takeda's dry eye drug Xiidra (lifitegrast ophthalmic solution) in a deal worth up to $5.5 billion, FAZ says on Friday (p20) (APMHE 62926).
Digital technologies to improve diabetes treatmentThe use of digital technologies will further improve diabetes treatment, Handelsblatt said on Wednesday (p20-21).
Paul-Ehrlich-Institut remains located in LangenThe German regulatory body Paul-Ehrlich-Institut (PEI), in charge of biological drugs and vaccines, will move to a newly constructed building in the city of Langen, near Frankfurt, close to its current location, reported FAZ on Wednesday (p42) and Thursday (p44).
Insys founder may be forced to sell its shares in AkornThe founder of U.S. manufacturer Insys Therapeutics John Kapoor, found guilty in a in U.S. opioid bribery lawsuit, may be forced to sell its shares in the company but also in U.S. generic drug maker Akorn, reported Handelsblatt on Monday (p54).
TRY APM HEALTH EUROPE AND GET ACCESS TO THE FULL CONTENT
Interviews with KOLs/senior executives amongst the Regulators, Payers, Health, Medical & Pharmaceutical organisations
Events coverage with a unique focus on Market Access & sustainability of healthcare systems
6 European bureaus : Berlin, Brussels, London, Madrid, Milan & Paris
Ask for a Free trial and get access to the latest stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.